Vending Machine Naloxone Distribution for Your Community (VENDY)

Status Not yet recruiting

Clinical Trial Summary

Vending machines are an innovative strategy shown to increase access to naloxone, a medication used to reverse opioid overdose. The aim of this proposal is to study the reach of a community-initiated, stakeholder engaged adaptation of naloxone distribution, VEnding machine Naloxone Distribution for Your community (VENDY) program.

Clinical Trial Description

This pilot assessment of the VENDY program will take place in 3 communities. Each community will have a machine (vending or kiosks) in which naloxone will be distributed for free to community members. Our preliminary work identified the locations desired by community members who use illegal drugs for machine placement. The pilot test test will include evaluation of the reach (naloxone distribution), adoption (% of sites and staff implementing), and implementation (fidelity to restocking and maintenance protocol) of VENDY in each community. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06429436
Study type	Interventional
Source	University of Colorado, Denver
Contact	Nicole Wagner, PhD
Phone	(303)724-7095
Email	nicole.wagner@cuanschutz.edu
Status	Not yet recruiting
Phase	Phase 4
Start date	June 1, 2024
Completion date	January 1, 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04372238` - The Rhode Island Prescription and Illicit Drug Study	N/A
Recruiting	`NCT03924505` - Preventing Opioid Overdose Mortality in the United States	N/A
Completed	`NCT05093309` - Preventing Opioid Overdose Deaths by Empowering Pharmacists to Dispense Naloxone	N/A
Completed	`NCT05219669` - Pharmacokinetic Evaluation of Intranasal Nalmefene Using Three Dosing Regimens	Phase 1
Completed	`NCT04317053` - Multi-Center Randomized Controlled Trial of Relay- NYC's Nonfatal Overdose Response Program	Phase 3
Not yet recruiting	`NCT06466005` - UnityPhilly Response App for Overdose Reversal
Recruiting	`NCT04815590` - Extended-release Injectable Buprenorphine for Individuals at High Risk of Overdose
Active, not recruiting	`NCT05096429` - Preventing Overdose Using Information and Data From the Environment	N/A
Suspended	`NCT05114460` - Vaped Marijuana to Attenuate Naloxone-Precipitated Withdrawal	Phase 2
Recruiting	`NCT06238128` - Opioid Rapid Response System: Naloxone Training in Communities	N/A
Completed	`NCT02662153` - Incidence and Predictors of Opioid Overdose and Death Among Long-Term Users of Opioid Analgesics
Active, not recruiting	`NCT05944133` - Health Insurance Instability and Mortality Among Patients Receiving Bup Tx for OUD
Completed	`NCT05377255` - Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy Adults	Phase 1
Recruiting	`NCT05877118` - Improving Availability of Intranasal Naloxone	N/A
Recruiting	`NCT05072249` - European Cohort Study of the Effectiveness of Take Home Naloxone
Withdrawn	`NCT05808881` - Clinical Outcomes From Nalmefene	Phase 4
Not yet recruiting	`NCT01622504` - Naloxone Nasal Spray Pharmacokinetic Study	Phase 1
Completed	`NCT05506267` - Development of a Tracheal Sound Sensor
Completed	`NCT02535494` - Risks and Benefits of Naloxone Prescribing	N/A
Not yet recruiting	`NCT06408714` - Nalmefene vs Naloxone for the Treatment of Recurrent Respiratory Depression After Opioid Overdose	Phase 3